Evaluation of the beneficial effects of pemafibrate in hypertriglyceridemia with or without alcohol drinking (PAR-CHAT: PARmodia-CHikushi Anti-dyslipidemia Trial)

Purpose: To examine the efficacy and safety of pemafibrate in outpatients with hypertriglyceridemia, including alcoholic hypertriglyceridemia. Method: This multicenter, open-label, prospective observational study (C20-07-009) included outpatients with hypertriglyceridemia being treated with pemafibr...

Full description

Saved in:
Bibliographic Details
Main Authors: Yosuke Takamiya, Chiyori Imanaga, Amane Ike, Akira Kawamura, Hidenori Urata
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:International Journal of Cardiology. Cardiovascular Risk and Prevention
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772487524001247
Tags: Add Tag
No Tags, Be the first to tag this record!